Navigation Links
Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date
Date:3/6/2009

ALISO VIEJO, Calif., March 6 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that its annual meeting of stockholders will be held on May 12, 2009 at 9:00 a.m. Eastern Time, at the Hilton Hotel located at 41 John F. Kennedy Parkway, Short Hills, New Jersey 07078. The record date for stockholders entitled to vote at the annual meeting is March 16, 2009.

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.

    Contact:
    Laurie W. Little
    Valeant Pharmaceuticals
    949-461-6002

(Logo: http://www.newscom.com/cgi-bin/prnh/20081125/VALEANTLOGO)


'/>"/>
SOURCE Valeant Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
2. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
3. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... 2015 , ... AlignLife Office Coordinator Heather Pugh earned the position ... patients at this natural health care center in Winamac. , "Oftentimes patients are in ... role is vital to our approach because we want to focus on the patient ...
(Date:8/1/2015)... ... 2015 , ... Western University of Health Sciences’ newest class ... growing percentage of U.S. physicians, and reflects the diversity of the communities where ... message delivered by John W. Becher, DO, president of the American Osteopathic Association, ...
(Date:8/1/2015)... TX (PRWEB) , ... August 01, 2015 , ... The ... concern among both men and women often causing pain and discomfort. Those who spend ... this circulatory problem, and Northeast Houston Vein Center is doing what it can to ...
(Date:8/1/2015)... ... August 01, 2015 , ... Tina Wilcoxson, owner of Freeport Maine’s Royal River ... honor by the National Retail Federation, the largest retail trade association in the world, ... Maine business owners to be named as such. According to the NRF’s website, Retail ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... ... Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & Wellness ... into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy ...
Breaking Medicine News(10 mins):Health News:New Patient Advocate Enhances Natural Health Care 2Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Local Retail Advocate Wins National Recognition 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2
... Peripheral Navigation, CTO ... Vessel Road Mapping at TCT 2007 ... ST. LOUIS, Oct. 19 Stereotaxis, Inc. (Nasdaq:,STXS) announced today ... Magnetic Navigation System at the,Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington,D.C., ...
... and Orthopedic Institute of Chicago Offer Complimentary Brain ... Women diagnosed with HER-2 positive Stage III or Stage IV ... to receive an MRI of the brain ... cancer that tests positive ...
... Israel, October 19 Healthcare,Technologies Ltd. (NASDAQ: HCTL ... shareholders, previously scheduled for September 30,2007, will be held ... offices of,Yigal Arnon & Co., 1 Azrieli Center, Round ... shareholders will be asked to approve the previously,announced Asset ...
... attributable to: Ronald M. Davis, M.D. AMA President: ... decision by,New York State Attorney General Andrew Cuomo ... programs used by health plans to,arbitrarily rank physicians. ... of empowering patients to become more,informed purchasers of ...
... headlines,claiming "soy products may lower sperm count" do not ... Dr. Jorge Chavarro from the Harvard,School of Public Health ... ( http://www.asrm.org ) was based on recollected intake,of soyfoods ... is,confounded by many issues, thus I feel the results ...
... MONICA, Calif., Oct. 18 The annual HMO,report ... so vague,and incomplete that it does not allow ... report omits key consumer information including,costs, medical failures ... HMOs, according to the Foundation for Taxpayer and ...
Cached Medicine News:Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 2Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 3Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 4Health News:Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month 2Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 2Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 3Health News:Real Men Eat Soy: The Truth about Soy and Sperm Count 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 3
(Date:8/2/2015)... Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... TELESTAR Phase 3 clinical trial met its primary ... in treating cancer patients with carcinoid syndrome that ... of care. Telotristat etiprate was discovered using Lexicon,s ... is the company,s first discovery to complete a ...
(Date:7/31/2015)... 31, 2015 Today, the National Association ... ) issued a report urging greater accountability by ... taken against websites illegally selling medications online. As ... Identification Program Progress Report for State and Federal ... of websites illegally distribute medications and avoid retribution. ...
(Date:7/31/2015)... TAMPA, Fla. , July 31, 2015 /PRNewswire/ ... announced today that it has made a structured ... -based company specializing in milling, micronization and ... investment will help grow Powdersize,s business while simultaneously ... solutions to Xcelience,s portfolio of capabilities. ...
Breaking Medicine Technology:Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... Perrigo Company (Nasdaq: PRGO ; TASE) and its ... tentative approval from the U.S. Food and Drug Administration for ... a generic version of UCB,s Xyzal® Oral Solution. Synthon believes ... generic that can entitle it to 180 days of generic ...
... -- Concord Medical Services Holdings Limited ("Concord Medical" ... of the largest network of radiotherapy and diagnostic imaging centers ... the first quarter ended March 31, 2011 (1). ... Total net revenues in the first quarter of 2011 ...
Cached Medicine Technology:Perrigo's Partner Synthon Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal® Oral Solution 2Perrigo's Partner Synthon Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal® Oral Solution 3Concord Medical Announces First Quarter 2011 Financial Results 2Concord Medical Announces First Quarter 2011 Financial Results 3Concord Medical Announces First Quarter 2011 Financial Results 4Concord Medical Announces First Quarter 2011 Financial Results 5Concord Medical Announces First Quarter 2011 Financial Results 6Concord Medical Announces First Quarter 2011 Financial Results 7Concord Medical Announces First Quarter 2011 Financial Results 8Concord Medical Announces First Quarter 2011 Financial Results 9Concord Medical Announces First Quarter 2011 Financial Results 10Concord Medical Announces First Quarter 2011 Financial Results 11Concord Medical Announces First Quarter 2011 Financial Results 12Concord Medical Announces First Quarter 2011 Financial Results 13
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: